Smartleaf Asset Management’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32K Hold
80
﹤0.01% 3048
2026
Q1
$928 Buy
80
+12
+18% +$172 ﹤0.01% 3129
2025
Q4
$1.06K Sell
68
-6
-8% -$110 ﹤0.01% 3152
2025
Q3
$1.62K Buy
74
+19
+35% +$424 ﹤0.01% 2659
2025
Q2
$1.21K Buy
+55
New +$1.22K ﹤0.01% 2444
2025
Q1
Sell
-28
Closed -$575 2982
2024
Q4
$575 Sell
28
-57
-67% -$1.5K ﹤0.01% 2761
2024
Q3
$2.71K Buy
85
+10
+13% +$295 ﹤0.01% 2379
2024
Q2
$1.82K Buy
+75
New +$1.92K ﹤0.01% 2260

Other funds holding SGRY

Smartleaf Asset Management's SGRY Position: Q2 2026 in Review

Smartleaf Asset Management held its Surgery Partners (SGRY) position steady in Q2 2026 at 80 shares worth $1.32K. The position accounts for ﹤0.01% of the portfolio, ranked #3048.

Smartleaf Asset Management first reported a position in SGRY in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.71K in Q3 2024. 187 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

  • Smartleaf Asset Management held 80 shares of Surgery Partners worth $1.32K as of Q2 2026.
  • Smartleaf Asset Management left its Surgery Partners share count unchanged in Q2 2026.
  • Surgery Partners made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #3048 holding.
  • Smartleaf Asset Management first reported a position in Surgery Partners in Q2 2024 and has held it in 8 quarters since.
  • Smartleaf Asset Management's Surgery Partners position peaked at $2.71K in Q3 2024.
  • 187 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.